Last updated on December 2017

Chronic Plaque Psoriasis

Brief description of study

ActivMed is participating in a clinical research study for people with moderate to severe chronic plaque psoriasis, and the opportunity to participate may be of interest to you. The BE VIVID study is looking at an investigational medication, called bimekizumab, to see if it is safe and effective for the treatment of moderate to severe chronic plaque psoriasis. 

If you qualify for the study, study medications, and all study-related care will be provided at no cost to you.



Clinical Study Identifier: TX155296

Contact Investigators or Research Sites near you

Start Over


ActivMed Practices & Research, Inc. NH
Portsmouth, NH United States
  Connect »